CVKD

Cadrenal Therapeutics Inc

NASDAQ · Pharmaceuticals
$5.70
+0.36 (+6.74%)
Analyst Consensus
Strong Buy
7 analysts
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +197.4% upside
Low Target $12.65
Average Target $16.95
High Target $22.59
Current Price $5.70
Current
$5.70
Target
$16.95
$12.65 $16.95 avg $22.59